The Sidney Kimmel Comprehensive Cancer Center
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private, Subsidiary
- Employees
- -
- Market Cap
- -
Skeletal Metastasis Registry
Terminated
- Conditions
- Metastatic Bone Tumor
- First Posted Date
- 2021-09-27
- Last Posted Date
- 2024-10-29
- Target Recruit Count
- 50
- Registration Number
- NCT05058014
- Locations
- 🇺🇸
Johns Hopkins, Baltimore, Maryland, United States
Phase II Trial of Venetoclax and Rituximab as Initial Therapy in Older Patients With Mantle Cell Lymphoma
Phase 2
Recruiting
- Conditions
- Mantle Cell Lymphoma
- Interventions
- First Posted Date
- 2021-08-27
- Last Posted Date
- 2024-06-20
- Target Recruit Count
- 40
- Registration Number
- NCT05025423
- Locations
- 🇺🇸
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States
Study of CRS-207, Pembrolizumab, Ipilimumab, and Tadalafil in Metastatic Pancreatic Cancer
Phase 2
Active, not recruiting
- Conditions
- Pancreatic Cancer
- Interventions
- First Posted Date
- 2021-08-20
- Last Posted Date
- 2025-04-16
- Target Recruit Count
- 17
- Registration Number
- NCT05014776
- Locations
- 🇺🇸
Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland, United States
Mutant KRAS -Targeted Long Peptide Vaccine for Patients at High Risk of Developing Pancreatic Cancer
Phase 1
Recruiting
- Conditions
- High Risk CancerPancreatic Cancer
- First Posted Date
- 2021-08-19
- Last Posted Date
- 2024-08-09
- Target Recruit Count
- 37
- Registration Number
- NCT05013216
- Locations
- 🇺🇸
Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland, United States
Trial of Cemiplimab, or Cemip-Chemo Followed by Biomarker-guided Treatment for Pts w/HPV H&N Ca
- First Posted Date
- 2021-08-03
- Last Posted Date
- 2024-12-17
- Target Recruit Count
- 32
- Registration Number
- NCT04988074
- Locations
- 🇺🇸
Johns Hopkins University, Baltimore, Maryland, United States
HPV in Sinonasal Ca: Retrospective Analysis Association of Human Papilloma Virus (HPV) Serology and Behavioral Risk Factors
Recruiting
- Conditions
- HPV-Related Squamous Cell CarcinomaSinonasal Carcinoma
- First Posted Date
- 2021-07-27
- Last Posted Date
- 2024-08-26
- Target Recruit Count
- 499
- Registration Number
- NCT04979000
- Locations
- 🇺🇸
Johns Hopkins University, Baltimore, Maryland, United States
6 Months Adjuvant Temozolomide (TMZ) vs No Adjuvant TMZ in Newly Diagnosed MGMT Methylated Glioblastoma (GBM)
Withdrawn
- Conditions
- MGMT-Methylated Glioblastoma
- Interventions
- Other: Standard of Care (SOC) Adjuvant TMZ (no interventionOther: Delay of TMZ
Incidence of Intracranial Hemorrhage in Glioma Patients With Venous Thromboembolism Converted From LMWH to Apixaban
Terminated
- Conditions
- Glioma, Malignant
- Interventions
- Other: Observation of ICH and VTE
- First Posted Date
- 2021-05-20
- Last Posted Date
- 2022-12-02
- Target Recruit Count
- 60
- Registration Number
- NCT04895553
- Locations
- 🇺🇸
UC Davis Comprehensive Cancer Center, Sacramento, California, United States
🇺🇸Johns Hopkins, Baltimore, Maryland, United States
Combination Radiotherapy and Radiopharmaceutical Therapy Treatment Planning for Thyroid Cancer
Phase 1
Recruiting
- Conditions
- Recurrent Thyroid Cancer
- Interventions
- Combination Product: Combination treatment (CXRPT) of external beam radiation (XRT) plus radioactive iodine (RAI)
- First Posted Date
- 2021-05-19
- Last Posted Date
- 2024-06-05
- Target Recruit Count
- 48
- Registration Number
- NCT04892303
- Locations
- 🇺🇸
The Johns Hopkins SKCCC, Baltimore, Maryland, United States
Neoadjuvant Targeting of Myeloid Cell Populations in Combination With Nivolumab in Head & Neck Ca
Phase 2
Recruiting
- Conditions
- Head and Neck Squamous Cell Carcinoma
- Interventions
- First Posted Date
- 2021-04-19
- Last Posted Date
- 2025-04-16
- Target Recruit Count
- 24
- Registration Number
- NCT04848116
- Locations
- 🇺🇸
Johns Hopkins University, Baltimore, Maryland, United States
© Copyright 2025. All Rights Reserved by MedPath